Once-Daily Administration of Aminoglycosides
- 1 June 1994
- journal article
- review article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 28 (6) , 757-766
- https://doi.org/10.1177/106002809402800614
Abstract
OBJECTIVE: To provide an overview of the efficacy and adverse effects associated with once-daily administration of aminoglycosides. DATA SOURCES: An extensive MEDLINE search and review of journals was conducted to identify information for this review. DATA SYNTHESIS: Aminoglycosides alone or in combination with beta-lactams are commonly used for their activity against gram-negative microorganisms. Numerous studies have been performed comparing efficacy and toxicity of once-daily administration of aminoglycosides with multiple-daily dosing. Two studies have found a significant difference in clinical efficacy between once-daily and multiple-daily dosing of aminoglycosides. Several studies have observed a lower incidence of toxicity with once-daily than multiple-daily dosing, but others have found no difference. CONCLUSIONS: Review of the literature suggests that once-daily administration of aminoglycosides may be as safe and effective as multiple-daily dosing regimens for the treatment of certain infections caused by gram-negative bacteria.Keywords
This publication has 67 references indexed in Scilit:
- What Price Success? The Continuing Saga of the Toxic: Therapeutic Ratio in the Use of Aminoglycoside AntibioticsThe Journal of Infectious Diseases, 1988
- Single, Large, Daily Dosing Versus Intermittent Dosing of Tobramycin for Treating Experimental Pseudomonas PneumoniaThe Journal of Infectious Diseases, 1988
- In Vivo Postantibiotic Effect in a Thigh Infection in Neutropenic MiceThe Journal of Infectious Diseases, 1988
- Serum Level Monitoring of Aminoglycoside AntibioticsArchives of Surgery, 1985
- In-vivo assessment of in-vitro killing patterns of Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 1985
- Postantibiotic effectsJournal of Antimicrobial Chemotherapy, 1985
- Risk Factors for the Development of Auditory Toxicity in Patients Receiving AminoglycosidesThe Journal of Infectious Diseases, 1983
- RANDOMISED, CONTROLLED TRIAL OF THE COMPARATIVE EFFICACY, AUDITORY TOXICITY, AND NEPHROTOXICITY OF TOBRAMYCIN AND NETILMICINThe Lancet, 1983
- Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patientsAntimicrobial Agents and Chemotherapy, 1982
- Dosage Schedules of Antimicrobial Agents: A Historical ReviewClinical Infectious Diseases, 1981